Related Experiment Video
Updated: May 7, 2026

08:00
Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
6.8K
Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program.
Daland R Juberg1, Susan J Borghoff, Richard A Becker
1Dow AgroSciences, Indianapolis, IN, USA.
ALTEX
|October 12, 2013
Summary
The U.S. Endocrine Disruptor Screening Program (EDSP) evaluated pesticides for endocrine disruption effects. A recent workshop gathered experts to review lessons learned and recommend future directions for this critical environmental health program.
Area of Science:
- Environmental Chemistry
- Toxicology
- Regulatory Science
Background:
- The U.S. Congress mandated endocrine pathway screening for pesticides and contaminants via the Food Quality Protection Act and Safe Drinking Water Act.
- The U.S. Environmental Protection Agency (EPA) established the Endocrine Disruptor Screening Program (EDSP) to address these requirements.
- EDSP focuses on developing and validating assays for estrogen, androgen, and thyroid (EAT) pathways.
Purpose of the Study:
- To review the performance and practical applications of EDSP Tier 1 screening assays.
- To gather insights from stakeholders on challenges and opportunities in endocrine disruptor testing.
- To inform future directions and improvements for the EDSP evaluations.
Main Methods:
- A workshop convened over 240 scientists from diverse sectors (government, industry, academia, non-profit).
- Discussions were organized into three sessions: Assay Performance, Data Application, and Future Testing.
- Retrospective analysis of data generated from EDSP Tier 1 assays was a key focus.
Main Results:
- Over 50 pesticide actives and 2 inert ingredients have been evaluated using EDSP Tier 1 assays (in vitro and in vivo).
- Key learnings and recommendations regarding the performance and application of EDSP Tier 1 assays were identified.
- The workshop highlighted practical applications of Tier 1 data and opportunities for future endocrine testing.
Conclusions:
- The EDSP has made progress in screening chemicals for endocrine disruption potential.
- Stakeholder collaboration is crucial for refining and advancing endocrine disruptor screening methodologies.
- Recommendations from the workshop will guide the future evolution of the EDSP.
Related Concept Videos
Endocrine Signaling
5.8K
5.8K
Endocrine Signaling
53.7K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
53.7K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Chemical Signaling in the Endocrine System
7.2K
A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
7.2K
Toxic Reactions: Overview
4.3K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.3K
Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K

